NCT05559060

Brief Summary

Epilepsy is the second commonest chronic neurological disorder in developed countries ,comorbidity refers to the co-occurrence of two conditions with greater frequency than found in the general population

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
165

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

September 29, 2022

Status Verified

September 1, 2022

Enrollment Period

8 months

First QC Date

September 24, 2022

Last Update Submit

September 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Find out comorbidities of epilesy and its treatment

    1 year

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects included will be chosen from epilepsy clinic and neurology department at assiut University hospital

You may qualify if:

  • Patients with primary epilepsy. Aged above 18 years old.

You may not qualify if:

  • patient diagnosed as secondary epilepsy or epilepsy syndromes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Hasnaa Abdallah Gaber

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

September 24, 2022

First Posted

September 29, 2022

Study Start

September 1, 2022

Primary Completion

May 1, 2023

Study Completion

June 1, 2023

Last Updated

September 29, 2022

Record last verified: 2022-09